Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Revenueshares Midcap | RWK | Nov 25, 2024 | 126.49 | +1.68 |
Revenueshares Smallcap | RWJ | Nov 25, 2024 | 49.46 | +2.42 |
Revenueshares Ultra Dividend Fund | RDIV | Nov 25, 2024 | 52.73 | +0.96 |
Reviva Pharmaceuticals | RVPH | Nov 25, 2024 | 1.15 | +0.88 |
Revolution Medicines | RVMD | Nov 25, 2024 | 57.50 | +1.32 |
Revolve Group A | RVLV | Nov 25, 2024 | 37.98 | +8.45 |
Revvity | RVTY | Nov 25, 2024 | 114.66 | +2.35 |
REX American Resources | REX | Nov 25, 2024 | 44.63 | -1.80 |
Rexford Industrial Realty | REXR | Nov 25, 2024 | 42.88 | +1.90 |
Rexford Industrial Realty B Pref | REXR-B | Nov 25, 2024 | 22.90 | +0.62 |
Rexford Industrial Realty C Pref | REXR-C | Nov 25, 2024 | 22.45 | +0.16 |
Reynolds Consumer Products | REYN | Nov 25, 2024 | 27.89 | +0.47 |
Rezolute | RZLT | Nov 25, 2024 | 4.86 | -1.02 |
Rezolve AI Limited - Ordinary Shares | RZLV | Nov 25, 2024 | 2.19 | +20.33 |
RF Acquisition A | RFAC | Nov 25, 2024 | 11.46 | 0.00 |
RF Acquisition Corp II | RFAIU | Nov 25, 2024 | 10.26 | 0.00 |
RF Acquisition II | RFAI | Nov 25, 2024 | 10.17 | -0.10 |
RF Industries | RFIL | Nov 25, 2024 | 4.04 | -0.74 |
RGC Resources | RGCO | Nov 25, 2024 | 21.40 | +0.75 |
RH | RH | Nov 25, 2024 | 389.14 | +5.74 |
Rhinebeck Bancorp | RBKB | Nov 25, 2024 | 9.79 | +0.41 |
Rhythm Pharmaceuticals | RYTM | Nov 25, 2024 | 59.92 | -0.03 |
Ribbon Communications | RBBN | Nov 25, 2024 | 3.86 | -1.03 |
Richardson Electronics | RELL | Nov 25, 2024 | 14.14 | -0.70 |
Richmond Mutual Bank | RMBI | Nov 25, 2024 | 14.25 | +2.52 |
Richtech Robotics | RR | Nov 25, 2024 | 0.63 | +2.41 |
Rigel Pharmaceuticals | RIGL | Nov 25, 2024 | 26.09 | +0.19 |
Rigetti Computing | RGTI | Nov 25, 2024 | 2.75 | +58.05 |
Riley Exploration Permian | REPX | Nov 25, 2024 | 36.03 | -2.30 |
Rimini Street | RMNI | Nov 25, 2024 | 2.05 | +2.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.